News
In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.
Biologic medical therapies, or biologics, are an important type of treatment for Crohn’s disease and inflammatory bowel disease. Biologics are a wide-ranging class of drugs, and there are many ...
TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group” or the “Company”) (TSX: AIF), a leading provider of asset and fund intelligence for commercial real estate (“CRE”), today ...
Revenue grew 9.6% YoY to RMB 18,675.4 million, with non-COVID revenue up 13.1% YoY Adjusted EBITDA grew 14.4% YoY to RMB7,999.3 million and Adjusted Net Profit increased 9.0% YoY to RMB5,396.9 million ...
Development The Group added 148 new development projects in 2024, further strengthening one of the industry’s largest portfolios of complex biologics. This portfolio includes 151 bispecifics & ...
The use of biologics is rapidly increasing as new drugs are approved for label expansions. Monoclonal antibodies, multispecific antibodies, and antibody-drug conjugates (ADCs) are being ...
Bengaluru: Syngene International Limited has announced the conclusion of the acquisition of its first biologics site in the USA, which was announced on March 10, 2025. The state-of-the-art biologics ...
Biologics targeting IL-12, IL-23, or IL-17 are linked to lower infection risk in older adults with psoriatic disease compared to other systemic treatments. The study utilized Ontario's health ...
LONDON--(BUSINESS WIRE)--Accenture (NYSE: ACN) has acquired Altus Consulting, a leader in consulting and digital transformation, to further strengthen its strategic advisory and delivery services ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results